428 related articles for article (PubMed ID: 9300746)
21. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
[TBL] [Abstract][Full Text] [Related]
22. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control.
Warde P; O'Sullivan B; Bristow RG; Panzarella T; Keane TJ; Gullane PJ; Witterick IP; Payne D; Liu FF; McLean M; Waldron J; Cummings BJ
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):347-53. PubMed ID: 9607350
[TBL] [Abstract][Full Text] [Related]
23. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system.
Murakami R; Nishimura R; Baba Y; Furusawa M; Ogata N; Yumoto E; Yamashita Y
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):471-5. PubMed ID: 15667969
[TBL] [Abstract][Full Text] [Related]
25. Treatment of early and moderately advanced vocal cord carcinoma with 6-MV X-rays.
Parsons JT; Greene BD; Speer TW; Kirkpatrick SA; Barhorst DB; Yanckowitz T
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):953-9. PubMed ID: 11429223
[TBL] [Abstract][Full Text] [Related]
26. Radiation therapy for T1 glottic cancer: involvement of the anterior commissure.
Nozaki M; Furuta M; Murakami Y; Izawa Y; Iwasaki N; Takahashi H; Watanabe K
Anticancer Res; 2000; 20(2B):1121-4. PubMed ID: 10810406
[TBL] [Abstract][Full Text] [Related]
27. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment.
Burke LS; Greven KM; McGuirt WT; Case D; Hoen HM; Raben M
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):37-42. PubMed ID: 9212002
[TBL] [Abstract][Full Text] [Related]
28. Accelerated radiotherapy for T1, 2 glottic carcinoma: analysis of results with KI-67 index.
Sakata K; Oouchi A; Nagakura H; Akiba H; Tamakawa M; Koito K; Hareyama M; Asakura K; Satoh M; Ohtani S
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):81-8. PubMed ID: 10758308
[TBL] [Abstract][Full Text] [Related]
29. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer.
Reddy SP; Mohideen N; Marra S; Marks JE
Radiother Oncol; 1998 May; 47(2):161-6. PubMed ID: 9683364
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of the results of surgery and radiotherapy in 175 cases of T2 glottic carcinoma: 116 operated and 59 irradiated cases].
Cellai E; Olmi P; Chiavacci A; Fallai C; Polli G; Aulisi L; Bottai GV; De Meester W
Radiol Med; 1991 Apr; 81(4):520-5. PubMed ID: 2028045
[TBL] [Abstract][Full Text] [Related]
31. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment.
Burke LS; Greven KM; McGuirt WT; Case D; Hoen HM; Raben M
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1001-6. PubMed ID: 9276365
[TBL] [Abstract][Full Text] [Related]
32. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
[TBL] [Abstract][Full Text] [Related]
33. Dynamic helical CT of T1 and T2 glottic carcinomas: predictive value for local control with radiation therapy.
Murakami R; Furusawa M; Baba Y; Nishimura R; Katsura F; Eura M; Masuyama K; Takahashi M
AJNR Am J Neuroradiol; 2000 Aug; 21(7):1320-6. PubMed ID: 10954287
[TBL] [Abstract][Full Text] [Related]
34. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy.
Kitani Y; Kubota A; Furukawa M; Sato K
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1011-7. PubMed ID: 25726168
[TBL] [Abstract][Full Text] [Related]
36. Multifactorial analysis of local control and survival in patients with early glottic cancer.
Nomura T; Ishikawa J; Ohki M; Ohata A; Araki R; Kikuchi S
Laryngoscope; 2020 Jul; 130(7):1701-1706. PubMed ID: 31397901
[TBL] [Abstract][Full Text] [Related]
37. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factor of telecobalt therapy for early glottic carcinoma.
Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
Cancer; 1992 Dec; 70(12):2797-801. PubMed ID: 1451057
[TBL] [Abstract][Full Text] [Related]
39. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
RĂ¼be C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
[TBL] [Abstract][Full Text] [Related]
40. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
Inoue T; Inoue T; Teshima T; Murayama S; Yamazaki H; Nose T; Tanaka E
Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]